• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1类和2类组蛋白去乙酰化酶的底物和抑制剂特异性

Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases.

作者信息

Hildmann Christian, Wegener Dennis, Riester Daniel, Hempel René, Schober Andreas, Merana Joachim, Giurato Laura, Guccione Salvatore, Nielsen Tine Kragh, Ficner Ralf, Schwienhorst Andreas

机构信息

Department of Molecular Genetics and Preparative Molecular Biology Institute for Microbiology und Genetics, Goettingen, Germany.

出版信息

J Biotechnol. 2006 Jun 25;124(1):258-70. doi: 10.1016/j.jbiotec.2006.01.030. Epub 2006 Mar 29.

DOI:10.1016/j.jbiotec.2006.01.030
PMID:16567013
Abstract

Histone deacetylases (HDACs) are key enzymes in the transcriptional regulation of gene expression in eukaryotic cells. In recent years HDACs have attracted considerable attention as promising new targets in anticancer therapy. Currently, different histone deacetylase subtypes are divided into four groups denoted as classes 1-4. Here, we compare in more detail representatives of class 1 HDACs and FB188 HDAH as a close bacterial homologue of class 2 HDAC6, in regard of substrate and inhibitor specificity. Structure comparison is used to identify candidate regions responsible for observed specificity differences. Knowledge of these structural elements expedite studies on the biochemical role of different HDAC subtypes as well as the development of highly selective HDAC inhibitors as antitumor agents.

摘要

组蛋白去乙酰化酶(HDACs)是真核细胞中基因表达转录调控的关键酶。近年来,HDACs作为抗癌治疗中有前景的新靶点受到了广泛关注。目前,不同的组蛋白去乙酰化酶亚型分为1-4类。在此,我们更详细地比较了1类HDACs的代表与FB188 HDAH(作为2类HDAC6的紧密细菌同源物)在底物和抑制剂特异性方面的情况。通过结构比较来确定导致观察到的特异性差异的候选区域。了解这些结构元件有助于加快对不同HDAC亚型生化作用的研究,以及开发作为抗肿瘤药物的高选择性HDAC抑制剂。

相似文献

1
Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases.1类和2类组蛋白去乙酰化酶的底物和抑制剂特异性
J Biotechnol. 2006 Jun 25;124(1):258-70. doi: 10.1016/j.jbiotec.2006.01.030. Epub 2006 Mar 29.
2
Structural origin of selectivity in class II-selective histone deacetylase inhibitors.II类选择性组蛋白去乙酰化酶抑制剂选择性的结构起源
J Med Chem. 2008 May 22;51(10):2898-906. doi: 10.1021/jm7015254. Epub 2008 Apr 16.
3
Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.迈向选择性组蛋白去乙酰化酶抑制剂设计:人类I类组蛋白去乙酰化酶的同源建模、对接研究及分子动力学模拟
J Med Chem. 2005 Nov 3;48(22):6936-47. doi: 10.1021/jm0505011.
4
Factors affecting the substrate specificity of histone deacetylases.影响组蛋白脱乙酰酶底物特异性的因素。
Biochem Biophys Res Commun. 2007 Jun 1;357(2):439-45. doi: 10.1016/j.bbrc.2007.03.158. Epub 2007 Apr 3.
5
Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.将羟肟酸对接进入 HDAC1 和 HDAC8:对活性趋势和选择性的合理化解释。
J Chem Inf Model. 2009 Dec;49(12):2774-85. doi: 10.1021/ci900288e.
6
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.人类HDAC8的结构快照为I类组蛋白去乙酰化酶提供了深入见解。
Structure. 2004 Jul;12(7):1325-34. doi: 10.1016/j.str.2004.04.012.
7
Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.“无连接子”异羟肟酸作为选择性HDAC8抑制剂的设计与评价
Bioorg Med Chem Lett. 2007 May 15;17(10):2874-8. doi: 10.1016/j.bmcl.2007.02.064. Epub 2007 Feb 25.
8
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.一种真核生物锌依赖性组蛋白脱乙酰酶——人类HDAC8与一种异羟肟酸抑制剂复合物的晶体结构。
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15064-9. doi: 10.1073/pnas.0404603101. Epub 2004 Oct 11.
9
An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme.一个活性位点酪氨酸残基对于酰胺水解酶活性是必需的,但对于一种2类组蛋白去乙酰化酶样细菌酶的酯酶活性并非必需。
Biochem J. 2007 Feb 1;401(3):659-65. doi: 10.1042/BJ20061239.
10
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.与TSA和SAHA抑制剂结合的组蛋白脱乙酰酶同源物的结构。
Nature. 1999 Sep 9;401(6749):188-93. doi: 10.1038/43710.

引用本文的文献

1
Bacterial protein acetylation: mechanisms, functions, and methods for study.细菌蛋白乙酰化:机制、功能及研究方法。
Front Cell Infect Microbiol. 2024 Jul 4;14:1408947. doi: 10.3389/fcimb.2024.1408947. eCollection 2024.
2
Moscatilin Suppresses the Breast Cancer Both In Vitro and In Vivo by Inhibiting HDAC3.毛柿素通过抑制组蛋白去乙酰化酶3在体外和体内抑制乳腺癌。
Dose Response. 2021 Mar 15;19(1):15593258211001251. doi: 10.1177/15593258211001251. eCollection 2021 Jan-Mar.
3
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing.
基于结构的虚拟筛选和体外测试鉴定新型曼氏血吸虫组蛋白去乙酰化酶 8(HDAC8)抑制剂。
Molecules. 2018 Mar 2;23(3):566. doi: 10.3390/molecules23030566.
4
ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research.ProSelection:一种为计算机辅助靶点识别和药物发现研究选择合适蛋白质结构子集的新算法。
J Chem Inf Model. 2017 Nov 27;57(11):2686-2698. doi: 10.1021/acs.jcim.7b00277. Epub 2017 Oct 26.
5
Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups.含异吲哚酮类帽状结构和邻苯二胺类锌结合基团的新型组蛋白去乙酰化酶抑制剂的设计、合成及抗肿瘤活性研究
Bioorg Med Chem. 2017 Jun 15;25(12):2981-2994. doi: 10.1016/j.bmc.2017.03.036. Epub 2017 Mar 19.
6
Chemical and structural biology of protein lysine deacetylases.蛋白质赖氨酸脱乙酰酶的化学与结构生物学
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(5):297-321. doi: 10.2183/pjab.93.019.
7
Osterix acetylation at K307 and K312 enhances its transcriptional activity and is required for osteoblast differentiation.osterix在K307和K312位点的乙酰化增强了其转录活性,是成骨细胞分化所必需的。
Oncotarget. 2016 Jun 21;7(25):37471-37486. doi: 10.18632/oncotarget.9650.
8
General Base-General Acid Catalysis in Human Histone Deacetylase 8.人类组蛋白去乙酰化酶8中的一般碱-一般酸催化作用
Biochemistry. 2016 Feb 9;55(5):820-32. doi: 10.1021/acs.biochem.5b01327. Epub 2016 Jan 25.
9
Use of epigenetic drugs in disease: an overview.表观遗传药物在疾病中的应用:综述
Genet Epigenet. 2014 May 27;6:9-19. doi: 10.4137/GEG.S12270. eCollection 2014.
10
Molecular modeling study on tunnel behavior in different histone deacetylase isoforms.不同组蛋白去乙酰化酶异构体中隧道行为的分子建模研究。
PLoS One. 2012;7(11):e49327. doi: 10.1371/journal.pone.0049327. Epub 2012 Nov 29.